Donald Trump JrBacked Enhanced Games Controversial Steroid Olympics Launches This Weekend with Broader Product Ambitions Analysts Suggest Ondas Inc ONDS May Have Additional Upside Potential Nvidia Stock Declines PostEarnings Why Sellers May Be Overlooking Key Growth Drivers New York Fed Study Reveals LowerIncome Households Feel the Pinch from Rising Gas Prices US Stock Markets Rally SP 500 Records Longest Winning Streak Since 2023 Dow Gains Over 2 Geopolitical Risk Remains Elevated as Iran Defies US Pressure Strait of Hormuz Uncertainty Persists ZTS Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges EXPE Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Resilient Travel Demand TIC Solutions Inc Q1 2026 Earnings Deep EPS Miss Highlights Ongoing Cost Pressures CXDO Q1 2026 Earnings EPS Surprises 256 Above Estimates SYNA Q1 2026 Earnings EPS Surpasses Estimates Shares Surge Goldman Sachs BDC Inc GSBD Q1 2026 Earnings EPS Miss Weighs on Shares Despite Steady Portfolio Performance Hanover Insurance Group THG Maintains Modest Uptrend Holding Above Key Support Beazer Homes BZH Rallies 178 as Homebuilder Sector Finds Support Near 2493 Fossil Group FOSL Edges Higher as Shares Test Key Resistance Level Advantage Solutions ADV Plunges Over 9 Key Support Levels in Focus Western Asset Bond Fund WEA Holds Steady Near 1055 Amid Narrow Trading Range Precision BioSciences DTIL Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported Stock Edges Higher Enterprise Financial Services Corporation EFSCP Q1 2026 Earnings Slight EPS Miss Amid Solid Capital Performance Lightbridge Corporation LTBR Q1 2026 Earnings Net Loss of 020 Per Share Continues Development Phase GOOD Q1 2026 Earnings Strong EPS Beat Despite Negative Market Reaction SRTS Q1 2026 Earnings EPS Falls Short of Estimates as Revenue Remains Undisclosed NEU Q1 2026 Earnings Strong EPS of 1262 Shares Advance 332 US Job Growth Figures Revised Downward New Data Indicates AVB Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Vistagen Therapeutics VTGN Approaches Key Support After Marginal Decline